These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 26851971

  • 1. Epigallocatechin Gallate Extends the Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment in Ischemic Rats.
    You YP.
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):990-7. PubMed ID: 26851971
    [Abstract] [Full Text] [Related]

  • 2. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model.
    Lu HT, Zhao JG, Li MH, Li YD.
    Brain Res; 2012 Feb 15; 1438():75-84. PubMed ID: 22227456
    [Abstract] [Full Text] [Related]

  • 3. Epigallocatechin Gallate Extends Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment for Brain Ischemic Stroke: A Randomized Double-Blind and Placebo-Controlled Trial.
    Wang XH, You YP.
    Clin Neuropharmacol; 2017 Feb 15; 40(1):24-28. PubMed ID: 27941526
    [Abstract] [Full Text] [Related]

  • 4. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
    Murakami K, Suzuki M, Suzuki N, Hamajo K, Tsukamoto T, Shimojo M.
    Brain Res; 2013 Aug 14; 1526():84-93. PubMed ID: 23791950
    [Abstract] [Full Text] [Related]

  • 5. TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.
    Cai Y, Liu X, Chen W, Wang Z, Xu G, Zeng Y, Ma Y.
    Exp Neurol; 2015 Apr 14; 266():120-6. PubMed ID: 25708985
    [Abstract] [Full Text] [Related]

  • 6. Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO--MMP-9 Pathway.
    Chen H, Guan B, Chen X, Chen X, Li C, Qiu J, Yang D, Liu KJ, Qi S, Shen J.
    Transl Stroke Res; 2018 Oct 14; 9(5):515-529. PubMed ID: 29275501
    [Abstract] [Full Text] [Related]

  • 7. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
    Liang J, Qi Z, Liu W, Wang P, Shi W, Dong W, Ji X, Luo Y, Liu KJ.
    Stroke; 2015 May 14; 46(5):1344-1351. PubMed ID: 25804925
    [Abstract] [Full Text] [Related]

  • 8. Experimental modeling of recombinant tissue plasminogen activator effects after ischemic stroke.
    El Amki M, Lerouet D, Coqueran B, Curis E, Orset C, Vivien D, Plotkine M, Marchand-Leroux C, Margaill I.
    Exp Neurol; 2012 Dec 14; 238(2):138-44. PubMed ID: 22921458
    [Abstract] [Full Text] [Related]

  • 9. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
    Zhang L, Zhang ZG, Ding GL, Jiang Q, Liu X, Meng H, Hozeska A, Zhang C, Li L, Morris D, Zhang RL, Lu M, Chopp M.
    Circulation; 2005 Nov 29; 112(22):3486-94. PubMed ID: 16316970
    [Abstract] [Full Text] [Related]

  • 10. The functional effect of epigallocatechin gallate on ischemic stroke in rats.
    Lim SH, Kim HS, Kim YK, Kim TM, Im S, Chung ME, Hong BY, Ko YJ, Kim HW, Lee JI.
    Acta Neurobiol Exp (Wars); 2010 Nov 29; 70(1):40-6. PubMed ID: 20407485
    [Abstract] [Full Text] [Related]

  • 11. Co-administration of liposomal fasudil and tissue plasminogen activator ameliorated ischemic brain damage in occlusion model rats prepared by photochemically induced thrombosis.
    Fukuta T, Yanagida Y, Asai T, Oku N.
    Biochem Biophys Res Commun; 2018 Jan 01; 495(1):873-877. PubMed ID: 29162447
    [Abstract] [Full Text] [Related]

  • 12. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
    Ma Y, Li L, Kong L, Zhu Z, Zhang W, Song J, Chang J, Du G.
    Biomed Res Int; 2018 Jan 01; 2018():8943210. PubMed ID: 29850586
    [Abstract] [Full Text] [Related]

  • 13. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
    Liu W, Hendren J, Qin XJ, Liu KJ.
    Stroke; 2009 Jul 01; 40(7):2526-31. PubMed ID: 19478225
    [Abstract] [Full Text] [Related]

  • 14. A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased neuroprotective efficacy and extended therapeutic time window.
    Maeda M, Furuichi Y, Ueyama N, Moriguchi A, Satoh N, Matsuoka N, Goto T, Yanagihara T.
    J Cereb Blood Flow Metab; 2002 Oct 01; 22(10):1205-11. PubMed ID: 12368659
    [Abstract] [Full Text] [Related]

  • 15. Bryostatin extends tPA time window to 6 h following middle cerebral artery occlusion in aged female rats.
    Tan Z, Lucke-Wold BP, Logsdon AF, Turner RC, Tan C, Li X, Hongpaison J, Alkon DL, Simpkins JW, Rosen CL, Huber JD.
    Eur J Pharmacol; 2015 Oct 05; 764():404-412. PubMed ID: 26189021
    [Abstract] [Full Text] [Related]

  • 16. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
    Allahtavakoli M, Amin F, Esmaeeli-Nadimi A, Shamsizadeh A, Kazemi-Arababadi M, Kennedy D.
    Basic Clin Pharmacol Toxicol; 2015 Nov 05; 117(5):335-9. PubMed ID: 25899606
    [Abstract] [Full Text] [Related]

  • 17. Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.
    Romanos E, Planas AM, Amaro S, Chamorro A.
    J Cereb Blood Flow Metab; 2007 Jan 05; 27(1):14-20. PubMed ID: 16596120
    [Abstract] [Full Text] [Related]

  • 18. Hemorrhagic profile of the fibrinolytic alfimeprase after ischemia and reperfusion.
    Lu A, Kurosawa Y, Luskey K, Pyne-Geithman G, Caudell D, Clark J.
    Neurol Res; 2009 Mar 05; 31(2):209-14. PubMed ID: 19298764
    [Abstract] [Full Text] [Related]

  • 19. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
    Zhang Z, Zhang L, Yepes M, Jiang Q, Li Q, Arniego P, Coleman TA, Lawrence DA, Chopp M.
    Circulation; 2002 Aug 06; 106(6):740-5. PubMed ID: 12163437
    [Abstract] [Full Text] [Related]

  • 20. Combination of Ligusticum chuanxiong and Radix Paeoniae ameliorate focal cerebral ischemic in MCAO rats via endoplasmic reticulum stress-dependent apoptotic signaling pathway.
    Gu J, Chen J, Yang N, Hou X, Wang J, Tan X, Feng L, Jia X.
    J Ethnopharmacol; 2016 Jul 01; 187():313-24. PubMed ID: 27108052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.